发明名称 |
PHARMACEUTICAL COMPOSITION CONTAINING SIBUTRAMINE AND ORLISTAT |
摘要 |
A method for the treatment of co-morbid conditions associated with obesity in a human in need of such treatment which comprises administration to the human of a therapeutically effective amount of a compound of formula (I) including enantiomers and pharmaceutically acceptable salts thereof, in which R1 and R2 are independently H or methyl, and a therapeutically effective amount of a compound of formula (II) wherein the compound of formula (I) and the compound of formula (II) are administered simultaneously, separately or sequentially.
|
申请公布号 |
WO0100205(A1) |
申请公布日期 |
2001.01.04 |
申请号 |
WO2000EP05542 |
申请日期 |
2000.06.16 |
申请人 |
KNOLL AKTIENGESELLSCHAFT;HEAL, DAVID, JOHN |
发明人 |
HEAL, DAVID, JOHN |
分类号 |
A61K31/397;A61K31/135;A61K31/365;A61P3/04;A61P3/06;A61P9/10;A61P9/12;A61P25/22;A61P25/24;A61P25/28;A61P25/30;(IPC1-7):A61K31/365 |
主分类号 |
A61K31/397 |
代理机构 |
|
代理人 |
|
主权项 |
|
地址 |
|